LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 962 | 1751 | 10315 | 0.1698 | 0.1912 |
MCF 10A | BX-912 | 3.33 | uM | LJP5 | 1 | L20 | 72 | hr | 962 | 1603 | 10714 | 0.1496 | 0.1581 |
MCF 10A | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 962 | 1542 | 10507 | 0.1468 | 0.1465 |
MCF 10A | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 962 | 1684 | 10315 | 0.1633 | 0.1777 |
MCF 10A | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 962 | 1148 | 10714 | 0.1072 | 0.0521 |
MCF 10A | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 962 | 1198 | 10507 | 0.1140 | 0.0656 |
MCF 10A | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 962 | 1140 | 10315 | 0.1105 | 0.0508 |
MCF 10A | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 962 | 5135 | 10693 | 0.4802 | 0.6193 |
MCF 10A | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 962 | 4991 | 10740 | 0.4647 | 0.6047 |
MCF 10A | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 962 | 4807 | 10641 | 0.4517 | 0.5903 |
MCF 10A | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 962 | 4180 | 10693 | 0.3909 | 0.5262 |
MCF 10A | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 962 | 4021 | 10740 | 0.3744 | 0.5081 |
MCF 10A | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 962 | 3613 | 10641 | 0.3395 | 0.4646 |
MCF 10A | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 962 | 3407 | 10693 | 0.3186 | 0.4390 |
MCF 10A | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 962 | 3474 | 10740 | 0.3234 | 0.4461 |
MCF 10A | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 962 | 2822 | 10641 | 0.2652 | 0.3639 |
MCF 10A | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 962 | 2649 | 10693 | 0.2477 | 0.3384 |
MCF 10A | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 962 | 2642 | 10740 | 0.2460 | 0.3367 |
MCF 10A | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 962 | 2343 | 10641 | 0.2202 | 0.2926 |
MCF 10A | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 962 | 2197 | 10693 | 0.2055 | 0.2683 |
MCF 10A | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 962 | 2379 | 10740 | 0.2215 | 0.2970 |
MCF 10A | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 962 | 2103 | 10641 | 0.1976 | 0.2530 |
MCF 10A | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 962 | 1721 | 10693 | 0.1609 | 0.1822 |
MCF 10A | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 962 | 1826 | 10740 | 0.1700 | 0.2021 |
MCF 10A | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 962 | 1531 | 10641 | 0.1439 | 0.1434 |